Advanced search
Publication Cover
Modern Rheumatology Volume 29, 2019 - Issue 2
Journal homepage
104
Views
1
CrossRef citations to date
0
Altmetric
Special Review: IL-6 inhibitor

“IL-6 is a treatment target for a variety of immune diseases”– The benefit and prospect of IL-6 inhibitor –

Yutaka KawahitoInflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JapanCorrespondence[email protected]
View further author information
Page 257 | Received 13 Dec 2018, Accepted 13 Dec 2018, Published online: 01 Feb 2019
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"“IL-6 is a treatment target for a variety of immune diseases”– The benefit and prospect of IL-6 inhibitor –." Modern Rheumatology, 29(2), p. 257

Conflict of interest

None.

Additional information

Funding

Yutaka Kawahito has received speaking fee, honoraria and/or research grants from Chugai Pharmaceutical Co., Ltd. and Asahikasei Pharm Corp.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.